Effectiveness and Safety of Lidocaine for Scleroderma
NCT00740285
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Scleroderma
Interventions
DRUG:
Lidocaine 2% without vessel constrictor
OTHER:
Placebo - physiological solution 0,9%
Sponsor
Federal University of São Paulo